Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

60
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
60
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

28
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
28
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

67
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
67
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

35
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
35
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

24
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Neuro-ophthalmology (Aeolus Press)·2019
Same author

Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease.

Clinical rheumatology·2019
Same author

Biologic Therapy for the Treatment of Giant Cell Arteritis.

Neuro-ophthalmology (Aeolus Press)·2016
Same author

Rituximab in the Treatment of Thyroid Eye Disease: A Review.

Neuro-ophthalmology (Aeolus Press)·2016
Same author

Rheumatoid arthritis, spondyloarthropathies, and relapsing polychondritis.

Handbook of clinical neurology·2013
Same author

Refractory adult-onset still disease successfully treated with abatacept.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2011

Related Experiment Video

Updated: Sep 17, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

862

Gout Management in Patients With CKD: A Review.

Rochella A Ostrowski1

  • 1Loyola University Medical Center, Maywood, Illinois; Edward Hines Jr Hospital, Veterans Administration, Hines, Illinois.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|July 3, 2025
PubMed
Summary

Managing gout in patients with chronic kidney disease (CKD) requires careful consideration of medication doses. This review explores optimal urate-lowering therapies and safety strategies for gout management in CKD patients.

Keywords:
Allopurinolchronic kidney diseasecolchicinefebuxostatgout

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Related Experiment Videos

Last Updated: Sep 17, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

862
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Area of Science:

  • Nephrology
  • Rheumatology
  • Pharmacology

Background:

  • Gout management in chronic kidney disease (CKD) presents unique challenges due to medication limitations.
  • Traditional dosing for urate-lowering therapies may lead to undertreatment of gout in CKD patients.

Purpose of the Study:

  • To review current guidelines and evidence for optimizing gout management in CKD patients.
  • To discuss appropriate dose adjustments for urate-lowering therapies beyond standard kidney-dosed limits.
  • To explore safety considerations, including allopurinol hypersensitivity syndrome and HLAB*5801 testing.

Main Methods:

  • Review of consensus group guidelines on gout management in CKD.
  • Literature review of risk factors for allopurinol hypersensitivity syndrome.
  • Evaluation of evidence for "start-low-go-low" approach and other management strategies.
  • Consideration of kidney transplant recipients and emerging therapies like pegloticase.

Main Results:

  • Standard dosing of urate-lowering therapies may be insufficient for gout control in CKD.
  • HLAB*5801 allele testing can inform allopurinol use and mitigate hypersensitivity risks.
  • The "start-low-go-low" approach offers a strategy for optimizing gout treatment safety and effectiveness in CKD.
  • Pegloticase, with immunomodulators, shows potential for refractory gout in CKD.

Conclusions:

  • Optimizing gout management in CKD requires individualized treatment plans and consideration of specific dosing strategies.
  • Careful patient selection and monitoring are crucial for safe and effective gout treatment in the context of kidney disease.
  • Further research into novel therapies and personalized approaches is needed to improve outcomes for CKD patients with gout.